Significantly Improving the Bioefficacy for Rheumatoid Arthritis with Supramolecular Nanoformulations.
Sign Up to like & getrecommendations! Published in 2021 at "Advanced materials"
DOI: 10.1002/adma.202100098
Abstract: As a typical inflammatory disease with chronic pain syndromes, rheumatoid arthritis (RA) generally requires long-term treatment with frequent injection administration at 1-2 times per day, because common medications such as interleukin1 receptor antagonist (IL1ra) have… read more here.
Keywords: bioefficacy rheumatoid; significantly improving; rheumatoid arthritis; arthritis ... See more keywords